{
    "study_accession": "SDY753",
    "actual_completion_date": null,
    "actual_enrollment": 47,
    "actual_start_date": "2013-01-01",
    "age_unit": "Years",
    "brief_description": "Microbiome alteration in response to influenza vaccine",
    "brief_title": "Investigating Alterations to the Nasal Microbiome after Vaccination with LAIV",
    "clinical_trial": "N",
    "condition_studied": "A/California/7/2009 (H1N1) and A/Victoria/361/2011 (H3N2))",
    "dcl_id": 2,
    "description": "The goal of this proposal is to characterize alterations to the nasal microbiome after vaccination with the 2012-2013 seasonal LAIV and to correlate these changes with LAIV-specific immune responses (A/California/7/2009 (H1N1) and A/Victoria/361/2011 (H3N2)).",
    "doi": "10.21430/M3ENN2D3SZ",
    "endpoints": "HA1 (H1N1/H3N2)",
    "gender_included": "Female, Male",
    "hypothesis": "Specific Aim 1: Measure changes in the nasal microbiome after vaccination with LAIV using high-throughput sequencing analysis of 16S rRNA genes; Correlate baseline and changes to the nasal microbiome after vaccination with LAIV vaccination with inter-individual differences in influenza-specific mucosal immune responses",
    "initial_data_release_date": "2016-03-18",
    "initial_data_release_version": "DR18",
    "intervention_agent": null,
    "latest_data_release_date": "2018-07-06",
    "latest_data_release_version": "DR27",
    "maximum_age": "  30.00",
    "minimum_age": "  18.00",
    "objectives": "Specific Aim 1: Measure changes in the nasal microbiome after vaccination with LAIV using high-throughput sequencing analysis of 16S rRNA genes; Correlate baseline and changes to the nasal microbiome after vaccination with LAIV vaccination with inter-individual differences in influenza-specific mucosal immune responses",
    "official_title": "Investigating Alterations to the Nasal Microbiome after Vaccination with LAIV",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 47,
    "workspace_id": 2510,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM3087",
            "description": "47 healthy adults age 18-30",
            "name": "healthy young adults"
        }
    ],
    "personnel": [
        {
            "first_name": "Gregory",
            "last_name": "Poland",
            "organization": "Mayo Clinic",
            "role_in_study": "Principal Investigator",
            "site_name": "Mayo Clinic"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Human Immunology Project Consortium (HIPC) RFA-AI-14-007",
            "contract_name": "Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISA",
            "number_of_expsamples": 94
        },
        {
            "measurement_technique": "Sequencing",
            "number_of_expsamples": 121
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Black or African American",
                "count": 3
            },
            {
                "race": "Other",
                "count": 1
            },
            {
                "race": "White",
                "count": 43
            }
        ],
        "gender": [
            {
                "Female": 27
            },
            {
                "Male": 20
            }
        ]
    }
}
